This article is brought to you in association with the European Parliament. MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance the security of supply, accessibility and affordability of medicines. On Tuesday, the Environment, Public Health and Food Safety Committee adopted its position on the new directive (66 votes in favour, […]EU pharmaceutical policy: MEPs support comprehensive reform
March 20, 2024 by Leave a Comment
This article is brought to you in association with the European Parliament. MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance the security of supply, accessibility and affordability of medicines. On Tuesday, the Environment, Public Health and Food Safety Committee adopted its position on the new directive (66 votes in favour, […]European Health Union: Commission proposes pharmaceuticals reform for more accessible, affordable and innovative medicines
April 27, 2023 by Leave a Comment
This article is brought to you in association with the European Commission. Today, the Commission is proposing to revise the EU’s pharmaceutical legislation – the largest reform in over 20 years – to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more […]In Africa’s free trade area, investment in pharmaceuticals means impact and profit
March 29, 2023 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Landry Signé, Senior Fellow, Global Economy and Development Program, Brookings Institution, Chido Munyati, Head of Regional Agenda, Africa, World Economic Forum The COVID-19 pandemic brushed away any doubt as to the importance of functioning and productive pharmaceutical industries. Countries […]6 ways the pharmaceutical industry can reduce its climate impact
November 28, 2022 by 1 Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Jayasree K. Iyer, CEO, Access to Medicine Foundation Health and climate are inextricably linked, from the impact of extreme weather on food security to air pollution due to wildfires or the growing spread of infectious diseases. Wherever we […]Affordable, accessible and safe medicines for all: the Commission presents a Pharmaceutical Strategy for Europe
November 25, 2020 by Leave a Comment
This article is brought to you in association with the European Commission. The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU’s pharmaceutical industry. The Strategy will allow Europe to cover its pharmaceutical needs, […]EU-U.S. trade talks: milestone reached in mutual recognition on pharmaceuticals
July 12, 2019 by Leave a Comment
This article is brought to you in association with the European Commission. Today, the European Union and the United States delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018. The positive transatlantic trade agenda established in the Joint Statement includes a commitment from both sides to reduce […]Pharmaceuticals in the environment: Commission defines actions to address risks and challenges
March 12, 2019 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission adopted yesterday a Communication outlining a set of actions addressing the multifaceted challenges that the release of pharmaceuticals poses to the environment. The “Strategic Approach to Pharmaceuticals in the Environment” that the Commission presents today, identifies six action areas concerning all […]How we can win the war against antibiotic resistance
January 10, 2019 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Kristina Lagerstedt, Founder and CEO, 1928 Diagnostics In 1945, Sir Alexander Fleming received the Nobel Prize in Medicine for the discovery of penicillin. In Sir Alexander’s acceptance remarks, he spoke of the responsibility that accompanied that discovery, namely that […]Pharmaceuticals: Commission refines intellectual property rules
May 29, 2018 by Leave a Comment
This article is brought to you in association with the European Commission. The Commission is proposing a targeted adjustment to intellectual property rules to help Europe’s pharmaceutical companies tap into fast-growing global markets and foster jobs, growth and investments in the EU. The EU has a strong intellectual property rights framework in place which protects Europe’s […]EU Commission – US hasten talks to avoid NGO reactions on free trade agreement
November 18, 2013 by Leave a Comment
Last Friday 15 November the European Union and the United States concluded the second round of Transatlantic Trade and Investment Partnership negotiations in Brussels. The TTIP is a kind of enlarged free trade agreement involving the two largest trading partners of the world. It covers mainly the impediments after the borders (regulations and technical barriers) […]High-technology manufacturing saves the EU industry
March 14, 2013 by Leave a Comment
According to a study by Eurostat, the EU statistical service, high and medium technology industries saved the manufacturing sector from a much larger fall during the difficult crisis years from 2008 until 2010. Still, the industrial sector has not yet fully recovered and in January 2013 compared to December 2012, seasonally adjusted overall industrial production fell […]Novartis and Johnson & Johnson to deprive Europeans of their right to Health
February 13, 2013 by 1 Comment
It was the last day of January that the European Commission decided to send a formal complaint against two pharmaceutical giants, Johnson and Johnson and Novartis, over an illegal secret deal that made European cancer patients suffer while it brought huge profits to the American and Swiss multinational accordingly. After the meticulous research of DG […]



















